Krishna Veeraraghavan Speaks on Healthcare Trends with Reuters

March 29, 2019

Reuters asked S&C M&A partner Krishna Veeraraghavan for his thoughts on trends in the healthcare industry in an article titled “Global M&A slides in first quarter as Brexit weighs on Europe.” Krishna explained that consolidation in the healthcare sector is unlikely to slow. “Between competition for new drugs, improving technology, the aging of the global population, a number of factors will continue to drive M&A in the healthcare sector, whether it's biotech or insurance providers,” he said. 
Krishna is well known in the healthcare industry, having advised on a number of the sector's largest deals, including INC Research Holdings in its $7.4 billion merger of equals with inVentiv Health, Stemcentrx in its $9.8 billion acquisition by AbbVie, and Teva Pharmaceutical Industries in its $40.5 billion acquisition of Allergan Generics, among others. He was named a Life Sciences MVP by Law360. To learn more about our leading healthcare lawyers and practice, click here